
Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis
pharmafile | July 24, 2020 | News story | Medical Communications | Eli Lilly, Humalog, diabetes, insulin
Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into its diabetes care section.
The company itself is planning to invest $400 million in expanding its facility in Indianapolis. The expansion will create 100 new jobs and make sure 20 current jobs are retained. Michael O’Conner, the Eli Lilly Senior Director of State Government Affairs, presented this proposal to the Indianapolis City-County Council Metropolitan and Economic Development Committee this week.
This request has not been submitted without controversy. Councillor Jared Evans, from District 22, said: “We already get screwed on sales tax, we get screwed on road infrastructure funding and much more, then we have to pay for tax incentives where 60% of these large corporations to go and live in other counties.”
Eli Lilly has consistently faced scrutiny over the years for the price of its insulin. It currently charges $275 per vial, which is a $150 increase from 2011. In April, the company announced that it will limit out of pocket costs for insulin to $35 per month to offset the financial conditions created by the coronavirus.
Conor Kavanagh
Related Content

Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …

Lilly’s drug for early Alzheimer’s shows promising results
Eli Lilly (Lilly) has announced positive new data from the long-term extension of its phase …

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …






